ResearcherXiyuan HospitalActive in the last 2 years
Bo Pang
Matched on ORCID iD 0000-0001-9664-3972; OpenAlex author ID A5039225458. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 6
2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 6
- Pi Ji Pills reshape the pancreatic cancer immune microenvironment and enhance the efficacy of gemcitabine through dual mechanisms of PI3K/AKT pathway blockade … Last author DOI 10.1016/j.jep.2025.120579↗
- Current and projected incidence rates of pancreatic cancer in 43 countries: an analysis of the Cancer Incidence in Five Continents database. Co-author DOI 10.1136/bmjgast-2024-001544↗
- Understanding, diagnosing, and treating pancreatic cancer from the perspective of telomeres and telomerase. Last author DOI 10.1038/s41417-024-00768-6↗
- SDC1 and ITGA2 as novel prognostic biomarkers for PDAC related to IPMN. Last author DOI 10.1038/s41598-023-44646-x↗
- Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic biomarker in pancreatic cancer. Last author DOI 10.18632/aging.205048↗
- Emerging current trends and research focus related to pancreatic cancer metabolism: A bibliometric and visualized analysis. Last author DOI 10.3389/fonc.2022.1009700↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chuanlong Zhang · 5 shared papers, 2022–2026 · strength 1.06
- Paper Pi Ji Pills reshape the pancreatic cancer immune microenvironment and enhance the efficacy of gemcitabine through dual … DOI 10.1016/j.jep.2025.120579↗
- Paper Understanding, diagnosing, and treating pancreatic cancer from the perspective of telomeres and telomerase. DOI 10.1038/s41417-024-00768-6↗
- Paper Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic … DOI 10.18632/aging.205048↗
- Yi Li · 4 shared papers, 2023–2026 · strength 0.93
- Paper Pi Ji Pills reshape the pancreatic cancer immune microenvironment and enhance the efficacy of gemcitabine through dual … DOI 10.1016/j.jep.2025.120579↗
- Paper Current and projected incidence rates of pancreatic cancer in 43 countries: an analysis of the Cancer Incidence in Five… DOI 10.1136/bmjgast-2024-001544↗
- Paper Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic … DOI 10.18632/aging.205048↗
- Qian Shen · 4 shared papers, 2022–2026 · strength 0.86
- Paper Pi Ji Pills reshape the pancreatic cancer immune microenvironment and enhance the efficacy of gemcitabine through dual … DOI 10.1016/j.jep.2025.120579↗
- Paper Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic … DOI 10.18632/aging.205048↗
- Paper SDC1 and ITGA2 as novel prognostic biomarkers for PDAC related to IPMN. DOI 10.1038/s41598-023-44646-x↗
- Songting Shou · 2 shared papers, 2024–2025 · strength 0.42
- Paper Current and projected incidence rates of pancreatic cancer in 43 countries: an analysis of the Cancer Incidence in Five… DOI 10.1136/bmjgast-2024-001544↗
- Paper Understanding, diagnosing, and treating pancreatic cancer from the perspective of telomeres and telomerase. DOI 10.1038/s41417-024-00768-6↗
- Baojin Hua · 1 shared paper, 2025 · strength 0.23
- Xing Zhang · 1 shared paper, 2025 · strength 0.23
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.